Management of Elevated Ferritin Levels
The first step in managing elevated ferritin is to determine whether it represents true iron overload or is due to non-iron overload causes such as inflammation, fatty liver disease, or metabolic syndrome, as this fundamentally determines treatment approach. 1
Diagnostic Evaluation
Initial Assessment
Complete iron studies panel:
- Serum ferritin
- Serum iron
- Total iron binding capacity (TIBC)
- Transferrin saturation
- Hemoglobin/hematocrit
Additional testing:
- Liver function tests (ALT, AST)
- C-reactive protein (inflammatory marker)
- Consider HFE gene testing if transferrin saturation >45-50%, especially in patients with European ancestry
Interpretation of Results
Transferrin saturation is the crucial differentiator:
45-50% with elevated ferritin: Suggests true iron overload
- Normal transferrin saturation with elevated ferritin: Suggests non-iron overload causes
Ferritin levels interpretation:
- <30 μg/L: Iron deficiency (without inflammation)
- 30-100 μg/L: Possible iron deficiency or anemia of chronic disease with inflammation
100 μg/L: Anemia of chronic disease or iron overload
1000 μg/L: Warrants specialist referral if cause remains unclear 2
2000 μg/L: Highly predictive of true iron overload 3
Management Based on Etiology
1. True Iron Overload
If transferrin saturation is elevated (>45-50%) and ferritin is consistently elevated:
Therapeutic phlebotomy:
- Initial frequency: Weekly (400-500 mL, containing 200-250 mg iron)
- Target ferritin level: 50-100 μg/L 1
- Monitor ferritin and transferrin saturation every 3 months during initial treatment, then annually once stabilized
Iron chelation therapy (e.g., deferasirox):
- Consider when phlebotomy is contraindicated
- Starting dose: 14 mg/kg/day for patients with eGFR >60 mL/min/1.73m² 4
- Target ferritin level: 500-1000 μg/L
- Monthly monitoring of:
- Serum ferritin
- Complete blood count
- Liver function
- Renal function
2. Non-Iron Overload Causes
For elevated ferritin with normal transferrin saturation, address the underlying cause:
Fatty liver disease/Metabolic syndrome:
- Weight loss
- Regular physical activity
- Dietary modifications
- Management of diabetes and dyslipidemia if present
Inflammatory conditions:
- Treat underlying inflammatory disorder
- Phlebotomy is not indicated 5
Alcohol-related liver disease:
- Alcohol cessation
- Liver-directed therapy
Special Considerations
Monitoring Iron Overload
- MRI assessment:
- Non-invasive method to quantify liver iron concentration
- Particularly useful in transfusion-dependent disorders
- T2 and T2* relaxometry are considered standard approaches 6
Ferritin Thresholds for Intervention
- If ferritin falls below 1000 μg/L at two consecutive visits, consider dose reduction of chelation therapy, especially if dose is high 4
- If ferritin falls below 500 μg/L, interrupt chelation therapy and continue monthly monitoring 4
- Serum ferritin should not exceed 500 mg/L in children and adolescents to avoid toxicity of iron overload 7
Cautions
- Do not evaluate iron parameters within 4 weeks of IV iron administration as this can interfere with assays 1
- Extremely high ferritin levels (>10,000 μg/L) may be associated with conditions like adult-onset Still's disease, hemophagocytic lymphohistiocytosis, or malignancy rather than simple iron overload 8
- Avoid overchelation, which can lead to serious adverse effects including renal impairment, hepatotoxicity, and bone marrow suppression 4
Referral Considerations
- Consider specialist referral (gastroenterologist, hematologist, or hepatologist) if:
- Ferritin >1000 μg/L
- Cause of elevated ferritin remains unclear after initial evaluation
- Evidence of organ damage
- Need for chelation therapy